CDMO providing fully integrated solutions in small molecule drug development & production from clinical stage to commercialization
Developing novel mRNA-based cancer therapies targeting solid tumors with high unmet need.
Precision medicine approach for autoimmune disorders using proprietary antibody-drug conjugate technology.
Targeting neurological disorders through blood-brain barrier penetrant small molecules.
Upgrade to access detailed therapeutic area information for this company and unlock all premium features.
